nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethynodiol—PGR—polycystic ovary syndrome	0.813	1	CbGaD
Ethynodiol—PGR—corpus luteum—polycystic ovary syndrome	0.0305	0.294	CbGeAlD
Ethynodiol—PGR—ovarian follicle—polycystic ovary syndrome	0.0238	0.23	CbGeAlD
Ethynodiol—ESR1—ovarian follicle—polycystic ovary syndrome	0.0186	0.18	CbGeAlD
Ethynodiol—PGR—Ovarian Infertility Genes—GDF9—polycystic ovary syndrome	0.00841	0.115	CbGpPWpGaD
Ethynodiol—PGR—Ovarian Infertility Genes—LHCGR—polycystic ovary syndrome	0.00322	0.0442	CbGpPWpGaD
Ethynodiol—PGR—Validated nuclear estrogen receptor alpha network—DDX54—polycystic ovary syndrome	0.00278	0.0381	CbGpPWpGaD
Ethynodiol—ESR1—embryo—polycystic ovary syndrome	0.00252	0.0243	CbGeAlD
Ethynodiol—PGR—Ovarian Infertility Genes—FSHR—polycystic ovary syndrome	0.00236	0.0324	CbGpPWpGaD
Ethynodiol—PGR—endometrium—polycystic ovary syndrome	0.00236	0.0227	CbGeAlD
Ethynodiol—PGR—uterus—polycystic ovary syndrome	0.00217	0.0209	CbGeAlD
Ethynodiol—PGR—pituitary gland—polycystic ovary syndrome	0.00213	0.0206	CbGeAlD
Ethynodiol—PGR—adipose tissue—polycystic ovary syndrome	0.00213	0.0205	CbGeAlD
Ethynodiol—PGR—adrenal gland—polycystic ovary syndrome	0.00191	0.0184	CbGeAlD
Ethynodiol—ESR1—endometrium—polycystic ovary syndrome	0.00184	0.0178	CbGeAlD
Ethynodiol—PGR—female gonad—polycystic ovary syndrome	0.00178	0.0171	CbGeAlD
Ethynodiol—PGR—vagina—polycystic ovary syndrome	0.00177	0.017	CbGeAlD
Ethynodiol—ESR1—uterus—polycystic ovary syndrome	0.0017	0.0164	CbGeAlD
Ethynodiol—ESR1—pituitary gland—polycystic ovary syndrome	0.00167	0.0161	CbGeAlD
Ethynodiol—ESR1—adipose tissue—polycystic ovary syndrome	0.00166	0.016	CbGeAlD
Ethynodiol—PGR—endocrine gland—polycystic ovary syndrome	0.00165	0.0159	CbGeAlD
Ethynodiol—ESR1—Validated nuclear estrogen receptor alpha network—DDX54—polycystic ovary syndrome	0.00163	0.0223	CbGpPWpGaD
Ethynodiol—ESR1—adrenal gland—polycystic ovary syndrome	0.00149	0.0144	CbGeAlD
Ethynodiol—PGR—Nuclear signaling by ERBB4—YAP1—polycystic ovary syndrome	0.00143	0.0196	CbGpPWpGaD
Ethynodiol—ESR1—female gonad—polycystic ovary syndrome	0.00139	0.0134	CbGeAlD
Ethynodiol—ESR1—vagina—polycystic ovary syndrome	0.00138	0.0133	CbGeAlD
Ethynodiol—PGR—Cellular roles of Anthrax toxin—IL18—polycystic ovary syndrome	0.00134	0.0184	CbGpPWpGaD
Ethynodiol—ESR1—endocrine gland—polycystic ovary syndrome	0.00129	0.0125	CbGeAlD
Ethynodiol—PGR—Ovarian Infertility Genes—CYP19A1—polycystic ovary syndrome	0.00117	0.016	CbGpPWpGaD
Ethynodiol—ESR1—Estrogen Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.00113	0.0155	CbGpPWpGaD
Ethynodiol—PGR—Nuclear signaling by ERBB4—PRL—polycystic ovary syndrome	0.00101	0.0138	CbGpPWpGaD
Ethynodiol—PGR—Ovarian Infertility Genes—NCOR1—polycystic ovary syndrome	0.000991	0.0136	CbGpPWpGaD
Ethynodiol—PGR—Nuclear Receptors—AR—polycystic ovary syndrome	0.000988	0.0136	CbGpPWpGaD
Ethynodiol—PGR—Nuclear signaling by ERBB4—NCOR1—polycystic ovary syndrome	0.000846	0.0116	CbGpPWpGaD
Ethynodiol—ESR1—Nuclear signaling by ERBB4—YAP1—polycystic ovary syndrome	0.000837	0.0115	CbGpPWpGaD
Ethynodiol—PGR—Nuclear signaling by ERBB4—NRG1—polycystic ovary syndrome	0.00083	0.0114	CbGpPWpGaD
Ethynodiol—PGR—Nuclear Receptors—NR3C1—polycystic ovary syndrome	0.000799	0.011	CbGpPWpGaD
Ethynodiol—ESR1—Estrogen signaling pathway—GNAS—polycystic ovary syndrome	0.000795	0.0109	CbGpPWpGaD
Ethynodiol—PGR—Nuclear Receptor transcription pathway—AR—polycystic ovary syndrome	0.000781	0.0107	CbGpPWpGaD
Ethynodiol—ESR1—Leptin signaling pathway—PDE3B—polycystic ovary syndrome	0.000769	0.0106	CbGpPWpGaD
Ethynodiol—PGR—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.000759	0.0104	CbGpPWpGaD
Ethynodiol—PGR—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.000759	0.0104	CbGpPWpGaD
Ethynodiol—Levonorgestrel—SRD5A1—polycystic ovary syndrome	0.000758	0.0726	CrCbGaD
Ethynodiol—ESR1—Nuclear Receptors—PGR—polycystic ovary syndrome	0.000746	0.0102	CbGpPWpGaD
Ethynodiol—ESR1—Nuclear signaling by ERBB4—PGR—polycystic ovary syndrome	0.000731	0.01	CbGpPWpGaD
Ethynodiol—Medroxyprogesterone Acetate—HSD3B2—polycystic ovary syndrome	0.000729	0.0698	CrCbGaD
Ethynodiol—ESR1—Signaling mediated by p38-alpha and p38-beta—ATF1—polycystic ovary syndrome	0.000706	0.00969	CbGpPWpGaD
Ethynodiol—PGR—Validated nuclear estrogen receptor alpha network—PRL—polycystic ovary syndrome	0.000679	0.00932	CbGpPWpGaD
Ethynodiol—Cyproterone acetate—AR—polycystic ovary syndrome	0.000661	0.0633	CrCbGaD
Ethynodiol—PGR—Nuclear Receptor transcription pathway—NR3C1—polycystic ovary syndrome	0.000632	0.00866	CbGpPWpGaD
Ethynodiol—ESR1—FOXM1 transcription factor network—CCNB1—polycystic ovary syndrome	0.00062	0.0085	CbGpPWpGaD
Ethynodiol—PGR—Nuclear Receptors—PPARG—polycystic ovary syndrome	0.000619	0.00849	CbGpPWpGaD
Ethynodiol—ESR1—Nuclear signaling by ERBB4—PRL—polycystic ovary syndrome	0.000593	0.00813	CbGpPWpGaD
Ethynodiol—ESR1—Nuclear Receptor transcription pathway—PGR—polycystic ovary syndrome	0.000589	0.00808	CbGpPWpGaD
Ethynodiol—ESR1—Nuclear Receptors—AR—polycystic ovary syndrome	0.00058	0.00796	CbGpPWpGaD
Ethynodiol—PGR—Validated nuclear estrogen receptor alpha network—NCOR1—polycystic ovary syndrome	0.000569	0.00781	CbGpPWpGaD
Ethynodiol—ESR1—Regulation of nuclear SMAD2/3 signaling—RUNX3—polycystic ovary syndrome	0.00056	0.00768	CbGpPWpGaD
Ethynodiol—Cyproterone acetate—CYP19A1—polycystic ovary syndrome	0.000553	0.053	CrCbGaD
Ethynodiol—PGR—Signaling by ERBB4—FGF18—polycystic ovary syndrome	0.000519	0.00711	CbGpPWpGaD
Ethynodiol—ESR1—FOXA1 transcription factor network—AR—polycystic ovary syndrome	0.000516	0.00707	CbGpPWpGaD
Ethynodiol—Norelgestromin—PGR—polycystic ovary syndrome	0.000498	0.0477	CrCbGaD
Ethynodiol—Allylestrenol—PGR—polycystic ovary syndrome	0.000498	0.0477	CrCbGaD
Ethynodiol—ESR1—Nuclear signaling by ERBB4—NCOR1—polycystic ovary syndrome	0.000497	0.00681	CbGpPWpGaD
Ethynodiol—ESR1—Validated nuclear estrogen receptor alpha network—PGR—polycystic ovary syndrome	0.000492	0.00674	CbGpPWpGaD
Ethynodiol—PGR—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.000489	0.00671	CbGpPWpGaD
Ethynodiol—ESR1—Nuclear signaling by ERBB4—NRG1—polycystic ovary syndrome	0.000487	0.00668	CbGpPWpGaD
Ethynodiol—PGR—Signaling by ERBB4—YAP1—polycystic ovary syndrome	0.00048	0.00658	CbGpPWpGaD
Ethynodiol—PGR—Signaling by ERBB4—GAB1—polycystic ovary syndrome	0.000474	0.00649	CbGpPWpGaD
Ethynodiol—ESR1—Nuclear Receptors—NR3C1—polycystic ovary syndrome	0.000469	0.00643	CbGpPWpGaD
Ethynodiol—ESR1—Signaling events mediated by HDAC Class II—NR3C1—polycystic ovary syndrome	0.000469	0.00643	CbGpPWpGaD
Ethynodiol—ESR1—ATF-2 transcription factor network—TH—polycystic ovary syndrome	0.000459	0.00629	CbGpPWpGaD
Ethynodiol—ESR1—Nuclear Receptor transcription pathway—AR—polycystic ovary syndrome	0.000458	0.00629	CbGpPWpGaD
Ethynodiol—ESR1—Estrogen signaling pathway—BCL2—polycystic ovary syndrome	0.00045	0.00617	CbGpPWpGaD
Ethynodiol—Norgestimate—PGR—polycystic ovary syndrome	0.000448	0.043	CrCbGaD
Ethynodiol—Cyproterone acetate—NR3C1—polycystic ovary syndrome	0.000448	0.0429	CrCbGaD
Ethynodiol—Nandrolone phenpropionate—AR—polycystic ovary syndrome	0.000446	0.0428	CrCbGaD
Ethynodiol—ESR1—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.000445	0.00611	CbGpPWpGaD
Ethynodiol—ESR1—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.000445	0.00611	CbGpPWpGaD
Ethynodiol—PGR—Signaling by ERBB4—TNRC6B—polycystic ovary syndrome	0.000423	0.00581	CbGpPWpGaD
Ethynodiol—PGR—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.000416	0.0057	CbGpPWpGaD
Ethynodiol—ESR1—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.000413	0.00566	CbGpPWpGaD
Ethynodiol—Medroxyprogesterone Acetate—AKR1C3—polycystic ovary syndrome	0.000404	0.0387	CrCbGaD
Ethynodiol—ESR1—AP-1 transcription factor network—TH—polycystic ovary syndrome	0.0004	0.00548	CbGpPWpGaD
Ethynodiol—ESR1—Validated nuclear estrogen receptor alpha network—PRL—polycystic ovary syndrome	0.000399	0.00547	CbGpPWpGaD
Ethynodiol—ESR1—AP-1 transcription factor network—TCF7L2—polycystic ovary syndrome	0.000396	0.00543	CbGpPWpGaD
Ethynodiol—Megestrol acetate—PGR—polycystic ovary syndrome	0.000385	0.0369	CrCbGaD
Ethynodiol—Testosterone Propionate—CYP17A1—polycystic ovary syndrome	0.000381	0.0365	CrCbGaD
Ethynodiol—Nandrolone phenpropionate—CYP19A1—polycystic ovary syndrome	0.000373	0.0358	CrCbGaD
Ethynodiol—ESR1—Nuclear Receptor transcription pathway—NR3C1—polycystic ovary syndrome	0.000371	0.00508	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—ZNF430—polycystic ovary syndrome	0.000365	0.00501	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—ZNF205—polycystic ovary syndrome	0.000365	0.00501	CbGpPWpGaD
Ethynodiol—ESR1—Nuclear Receptors—PPARG—polycystic ovary syndrome	0.000363	0.00498	CbGpPWpGaD
Ethynodiol—PGR—Signaling by ERBB4—PRL—polycystic ovary syndrome	0.00034	0.00466	CbGpPWpGaD
Ethynodiol—Nandrolone decanoate—AR—polycystic ovary syndrome	0.000338	0.0324	CrCbGaD
Ethynodiol—ESR1—Validated nuclear estrogen receptor alpha network—NCOR1—polycystic ovary syndrome	0.000334	0.00458	CbGpPWpGaD
Ethynodiol—ESR1—Plasma membrane estrogen receptor signaling—IGF1—polycystic ovary syndrome	0.000324	0.00445	CbGpPWpGaD
Ethynodiol—ESR1—FOXA1 transcription factor network—INS—polycystic ovary syndrome	0.000317	0.00435	CbGpPWpGaD
Ethynodiol—ESR1—Regulation of nuclear SMAD2/3 signaling—AR—polycystic ovary syndrome	0.000317	0.00434	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—ADARB1—polycystic ovary syndrome	0.000311	0.00426	CbGpPWpGaD
Ethynodiol—ESR1—Signaling by ERBB4—FGF18—polycystic ovary syndrome	0.000304	0.00417	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000296	0.00406	CbGpPWpGaD
Ethynodiol—ESR1—AP-1 transcription factor network—NR3C1—polycystic ovary syndrome	0.000288	0.00395	CbGpPWpGaD
Ethynodiol—ESR1—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.000287	0.00394	CbGpPWpGaD
Ethynodiol—ESR1—Leptin signaling pathway—BAX—polycystic ovary syndrome	0.000287	0.00393	CbGpPWpGaD
Ethynodiol—PGR—Signaling by ERBB4—NCOR1—polycystic ovary syndrome	0.000285	0.00391	CbGpPWpGaD
Ethynodiol—Nandrolone decanoate—CYP19A1—polycystic ovary syndrome	0.000283	0.0271	CrCbGaD
Ethynodiol—ESR1—Signaling by ERBB4—YAP1—polycystic ovary syndrome	0.000282	0.00386	CbGpPWpGaD
Ethynodiol—PGR—Signaling by ERBB4—NRG1—polycystic ovary syndrome	0.00028	0.00384	CbGpPWpGaD
Ethynodiol—ESR1—Signaling by ERBB4—GAB1—polycystic ovary syndrome	0.000278	0.00381	CbGpPWpGaD
Ethynodiol—ESR1—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	0.000277	0.0038	CbGpPWpGaD
Ethynodiol—Levonorgestrel—PGR—polycystic ovary syndrome	0.000274	0.0263	CrCbGaD
Ethynodiol—Levonorgestrel—SHBG—polycystic ovary syndrome	0.000257	0.0246	CrCbGaD
Ethynodiol—ESR1—Regulation of nuclear SMAD2/3 signaling—NR3C1—polycystic ovary syndrome	0.000256	0.00351	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—LSM5—polycystic ovary syndrome	0.000253	0.00347	CbGpPWpGaD
Ethynodiol—ESR1—ATF-2 transcription factor network—INS—polycystic ovary syndrome	0.000251	0.00344	CbGpPWpGaD
Ethynodiol—ESR1—Signaling by ERBB4—TNRC6B—polycystic ovary syndrome	0.000249	0.00341	CbGpPWpGaD
Ethynodiol—ESR1—Signaling by ERBB4—PGR—polycystic ovary syndrome	0.000246	0.00337	CbGpPWpGaD
Ethynodiol—ESR1—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.000244	0.00335	CbGpPWpGaD
Ethynodiol—ESR1—Leptin signaling pathway—LEP—polycystic ovary syndrome	0.000242	0.00332	CbGpPWpGaD
Ethynodiol—PGR—Signaling by ERBB4—IRS2—polycystic ovary syndrome	0.00024	0.00329	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000237	0.00326	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000237	0.00326	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—SAP30L—polycystic ovary syndrome	0.000235	0.00323	CbGpPWpGaD
Ethynodiol—Testosterone Propionate—AR—polycystic ovary syndrome	0.000231	0.0222	CrCbGaD
Ethynodiol—Levonorgestrel—AR—polycystic ovary syndrome	0.000225	0.0216	CrCbGaD
Ethynodiol—Medroxyprogesterone Acetate—PGR—polycystic ovary syndrome	0.000224	0.0215	CrCbGaD
Ethynodiol—Norethindrone—PGR—polycystic ovary syndrome	0.000222	0.0213	CrCbGaD
Ethynodiol—ESR1—Integrated Breast Cancer Pathway—ATF1—polycystic ovary syndrome	0.000219	0.00301	CbGpPWpGaD
Ethynodiol—ESR1—Leptin signaling pathway—IRS1—polycystic ovary syndrome	0.000216	0.00296	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—ZNF430—polycystic ovary syndrome	0.000214	0.00294	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—ZNF205—polycystic ovary syndrome	0.000214	0.00294	CbGpPWpGaD
Ethynodiol—Megestrol acetate—NR3C1—polycystic ovary syndrome	0.000214	0.0205	CrCbGaD
Ethynodiol—ESR1—ATF-2 transcription factor network—BCL2—polycystic ovary syndrome	0.000212	0.0029	CbGpPWpGaD
Ethynodiol—Medroxyprogesterone Acetate—SHBG—polycystic ovary syndrome	0.00021	0.0201	CrCbGaD
Ethynodiol—PGR—Signaling by ERBB4—IRS1—polycystic ovary syndrome	0.000209	0.00287	CbGpPWpGaD
Ethynodiol—Norethindrone—SHBG—polycystic ovary syndrome	0.000208	0.0199	CrCbGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000205	0.00281	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Breast Cancer Pathway—TAB1—polycystic ovary syndrome	0.000202	0.00278	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—TEAD2—polycystic ovary syndrome	0.0002	0.00274	CbGpPWpGaD
Ethynodiol—ESR1—Signaling by ERBB4—PRL—polycystic ovary syndrome	0.0002	0.00274	CbGpPWpGaD
Ethynodiol—PGR—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.000199	0.00272	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Breast Cancer Pathway—CYP19A1—polycystic ovary syndrome	0.000198	0.00271	CbGpPWpGaD
Ethynodiol—PGR—Signaling by ERBB4—AKT2—polycystic ovary syndrome	0.000194	0.00266	CbGpPWpGaD
Ethynodiol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000193	0.00265	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Breast Cancer Pathway—AR—polycystic ovary syndrome	0.000192	0.00264	CbGpPWpGaD
Ethynodiol—Levonorgestrel—CYP19A1—polycystic ovary syndrome	0.000188	0.018	CrCbGaD
Ethynodiol—Medroxyprogesterone Acetate—AR—polycystic ovary syndrome	0.000184	0.0176	CrCbGaD
Ethynodiol—ESR1—Gene Expression—ADARB1—polycystic ovary syndrome	0.000182	0.0025	CbGpPWpGaD
Ethynodiol—ESR1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	0.000179	0.00245	CbGpPWpGaD
Ethynodiol—Progesterone—CYP17A1—polycystic ovary syndrome	0.000175	0.0167	CrCbGaD
Ethynodiol—ESR1—Signaling by ERBB4—NCOR1—polycystic ovary syndrome	0.000167	0.00229	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000165	0.00226	CbGpPWpGaD
Ethynodiol—ESR1—Signaling by ERBB4—NRG1—polycystic ovary syndrome	0.000164	0.00225	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Breast Cancer Pathway—BAX—polycystic ovary syndrome	0.000164	0.00225	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000159	0.00219	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—LSM5—polycystic ovary syndrome	0.000149	0.00204	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—NPB—polycystic ovary syndrome	0.000144	0.00197	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—RPL37A—polycystic ovary syndrome	0.000143	0.00196	CbGpPWpGaD
Ethynodiol—ESR1—Signaling by ERBB4—IRS2—polycystic ovary syndrome	0.000141	0.00193	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000139	0.00191	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000139	0.00191	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—SAP30L—polycystic ovary syndrome	0.000138	0.00189	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000136	0.00186	CbGpPWpGaD
Ethynodiol—PGR—Generic Transcription Pathway—AR—polycystic ovary syndrome	0.000135	0.00185	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00013	0.00178	CbGpPWpGaD
Ethynodiol—Progesterone—PGR—polycystic ovary syndrome	0.00013	0.0124	CrCbGaD
Ethynodiol—Medroxyprogesterone Acetate—NR3C1—polycystic ovary syndrome	0.000125	0.012	CrCbGaD
Ethynodiol—ESR1—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	0.000123	0.00169	CbGpPWpGaD
Ethynodiol—ESR1—Signaling by ERBB4—IRS1—polycystic ovary syndrome	0.000123	0.00168	CbGpPWpGaD
Ethynodiol—Progesterone—SHBG—polycystic ovary syndrome	0.000121	0.0116	CrCbGaD
Ethynodiol—PGR—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00012	0.00165	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00012	0.00165	CbGpPWpGaD
Ethynodiol—PGR—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.000118	0.00162	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—TEAD2—polycystic ovary syndrome	0.000117	0.00161	CbGpPWpGaD
Ethynodiol—ESR1—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.000117	0.0016	CbGpPWpGaD
Ethynodiol—ESR1—Signaling by ERBB4—AKT2—polycystic ovary syndrome	0.000114	0.00156	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000112	0.00154	CbGpPWpGaD
Ethynodiol—ESR1—ATF-2 transcription factor network—IL6—polycystic ovary syndrome	0.00011	0.0015	CbGpPWpGaD
Ethynodiol—PGR—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.000109	0.0015	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000109	0.0015	CbGpPWpGaD
Ethynodiol—Progesterone—AR—polycystic ovary syndrome	0.000106	0.0102	CrCbGaD
Ethynodiol—PGR—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000106	0.00145	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000103	0.00142	CbGpPWpGaD
Ethynodiol—ESR1—Generic Transcription Pathway—PGR—polycystic ovary syndrome	0.000102	0.0014	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	9.98e-05	0.00137	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—FLT4—polycystic ovary syndrome	9.66e-05	0.00133	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—PDE3B—polycystic ovary syndrome	9.65e-05	0.00132	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—YAP1—polycystic ovary syndrome	9.56e-05	0.00131	CbGpPWpGaD
Ethynodiol—ESR1—AP-1 transcription factor network—IL6—polycystic ovary syndrome	9.55e-05	0.00131	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	9.47e-05	0.0013	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—FSHR—polycystic ovary syndrome	8.79e-05	0.00121	CbGpPWpGaD
Ethynodiol—PGR—Signaling by ERBB4—IL6—polycystic ovary syndrome	8.75e-05	0.0012	CbGpPWpGaD
Ethynodiol—PGR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	8.45e-05	0.00116	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—NPB—polycystic ovary syndrome	8.44e-05	0.00116	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—TNRC6B—polycystic ovary syndrome	8.44e-05	0.00116	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—RPL37A—polycystic ovary syndrome	8.37e-05	0.00115	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	8.27e-05	0.00113	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—RACGAP1—polycystic ovary syndrome	8.26e-05	0.00113	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—ADRA1A—polycystic ovary syndrome	8.04e-05	0.0011	CbGpPWpGaD
Ethynodiol—ESR1—Generic Transcription Pathway—AR—polycystic ovary syndrome	7.92e-05	0.00109	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—FST—polycystic ovary syndrome	7.83e-05	0.00107	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—ADRB3—polycystic ovary syndrome	7.74e-05	0.00106	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—LHB—polycystic ovary syndrome	7.65e-05	0.00105	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	7.64e-05	0.00105	CbGpPWpGaD
Ethynodiol—PGR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	7.61e-05	0.00104	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—GNRH1—polycystic ovary syndrome	7.47e-05	0.00103	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	7.47e-05	0.00102	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	7.24e-05	0.000993	CbGpPWpGaD
Ethynodiol—Progesterone—NR3C1—polycystic ovary syndrome	7.2e-05	0.0069	CrCbGaD
Ethynodiol—PGR—Signaling Pathways—SCT—polycystic ovary syndrome	7.17e-05	0.000983	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—PTGER3—polycystic ovary syndrome	7.05e-05	0.000967	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—LHCGR—polycystic ovary syndrome	7.05e-05	0.000967	CbGpPWpGaD
Ethynodiol—ESR1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	6.92e-05	0.000949	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	6.84e-05	0.000937	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—FGF18—polycystic ovary syndrome	6.72e-05	0.000921	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—RBP4—polycystic ovary syndrome	6.66e-05	0.000914	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—PTAFR—polycystic ovary syndrome	6.59e-05	0.000904	CbGpPWpGaD
Ethynodiol—Progesterone—CYP1A1—polycystic ovary syndrome	6.54e-05	0.00627	CrCbGaD
Ethynodiol—PGR—Gene Expression—AR—polycystic ovary syndrome	6.5e-05	0.000891	CbGpPWpGaD
Ethynodiol—ESR1—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	6.4e-05	0.000878	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	6.4e-05	0.000878	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	6.23e-05	0.000854	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—YAP1—polycystic ovary syndrome	6.22e-05	0.000853	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	6.19e-05	0.000849	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—GAB1—polycystic ovary syndrome	6.13e-05	0.000841	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—INHBB—polycystic ovary syndrome	6.07e-05	0.000832	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—INSR—polycystic ovary syndrome	5.86e-05	0.000804	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—NCOR1—polycystic ovary syndrome	5.68e-05	0.000779	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—PDE3B—polycystic ovary syndrome	5.66e-05	0.000777	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—YAP1—polycystic ovary syndrome	5.61e-05	0.00077	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	5.57e-05	0.000764	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	5.49e-05	0.000752	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—NR3C1—polycystic ovary syndrome	5.25e-05	0.00072	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—FSHR—polycystic ovary syndrome	5.16e-05	0.000708	CbGpPWpGaD
Ethynodiol—ESR1—Signaling by ERBB4—IL6—polycystic ovary syndrome	5.14e-05	0.000705	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—GHRL—polycystic ovary syndrome	5.05e-05	0.000692	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—PLAT—polycystic ovary syndrome	5.05e-05	0.000692	CbGpPWpGaD
Ethynodiol—ESR1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	4.96e-05	0.00068	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—TNRC6B—polycystic ovary syndrome	4.95e-05	0.000679	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—PGR—polycystic ovary syndrome	4.9e-05	0.000672	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	4.85e-05	0.000665	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—ATF1—polycystic ovary syndrome	4.82e-05	0.000661	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	4.72e-05	0.000647	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	4.7e-05	0.000644	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—FST—polycystic ovary syndrome	4.6e-05	0.000631	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.54e-05	0.000623	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—LHB—polycystic ovary syndrome	4.49e-05	0.000616	CbGpPWpGaD
Ethynodiol—ESR1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	4.47e-05	0.000613	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—NGFR—polycystic ovary syndrome	4.44e-05	0.00061	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—PRL—polycystic ovary syndrome	4.4e-05	0.000604	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.39e-05	0.000602	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.25e-05	0.000583	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—SCT—polycystic ovary syndrome	4.21e-05	0.000577	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.18e-05	0.000573	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—PPARG—polycystic ovary syndrome	4.07e-05	0.000558	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.01e-05	0.00055	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—FGF18—polycystic ovary syndrome	3.94e-05	0.000541	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—RBP4—polycystic ovary syndrome	3.91e-05	0.000536	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—GNAS—polycystic ovary syndrome	3.87e-05	0.000531	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—AR—polycystic ovary syndrome	3.81e-05	0.000523	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.69e-05	0.000506	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—SERPINE1—polycystic ovary syndrome	3.67e-05	0.000503	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—YAP1—polycystic ovary syndrome	3.65e-05	0.000501	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—NRG1—polycystic ovary syndrome	3.62e-05	0.000497	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—GAB1—polycystic ovary syndrome	3.6e-05	0.000494	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—INSR—polycystic ovary syndrome	3.44e-05	0.000472	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—NCOR1—polycystic ovary syndrome	3.33e-05	0.000457	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.27e-05	0.000449	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.22e-05	0.000442	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—PGR—polycystic ovary syndrome	3.19e-05	0.000437	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—IRS2—polycystic ovary syndrome	3.1e-05	0.000426	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—NR3C1—polycystic ovary syndrome	3.08e-05	0.000423	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—LEP—polycystic ovary syndrome	3.04e-05	0.000417	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—PLAT—polycystic ovary syndrome	2.96e-05	0.000406	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—GHRL—polycystic ovary syndrome	2.96e-05	0.000406	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—ATF1—polycystic ovary syndrome	2.83e-05	0.000388	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.76e-05	0.000378	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—IRS1—polycystic ovary syndrome	2.71e-05	0.000372	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—POMC—polycystic ovary syndrome	2.61e-05	0.000358	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—NGFR—polycystic ovary syndrome	2.61e-05	0.000358	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—INS—polycystic ovary syndrome	2.59e-05	0.000356	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—PRL—polycystic ovary syndrome	2.59e-05	0.000355	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—IGF1—polycystic ovary syndrome	2.51e-05	0.000344	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—AKT2—polycystic ovary syndrome	2.51e-05	0.000344	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.45e-05	0.000336	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—PPARG—polycystic ovary syndrome	2.39e-05	0.000327	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.38e-05	0.000327	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—GNAS—polycystic ovary syndrome	2.27e-05	0.000312	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.17e-05	0.000297	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—SERPINE1—polycystic ovary syndrome	2.15e-05	0.000295	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—NRG1—polycystic ovary syndrome	2.13e-05	0.000292	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.82e-05	0.00025	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—LEP—polycystic ovary syndrome	1.78e-05	0.000244	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.64e-05	0.000225	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.59e-05	0.000218	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—POMC—polycystic ovary syndrome	1.53e-05	0.00021	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—INS—polycystic ovary syndrome	1.52e-05	0.000209	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.47e-05	0.000202	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.47e-05	0.000202	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.4e-05	0.000192	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—IL6—polycystic ovary syndrome	1.13e-05	0.000155	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.62e-06	0.000132	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—IL6—polycystic ovary syndrome	6.65e-06	9.13e-05	CbGpPWpGaD
